Vivanza Biosciences Ltd Board Meeting Scheduled to Discuss Auditor Appointment and Director Addition
Vivanza Biosciences Ltd has scheduled a meeting of its Board of Directors on Wednesday, June 18, 2026, to review several key corporate matters, including the appointment of an internal auditor and the addition of a new director.The board meeting is set to consider critical business items related to financial reporting and governance structure. Among the agenda points is the authorization of Mr. Sarang Bharatbhai Pathak (DIN: 02663344) to sign the Financial Statements for the financial year ended March 31, 2026, on behalf of the Board.
The company will also take note of the consent received from M/s Dharti Shah & Co. and approve their appointment as an Internal Auditor for the Financial Year 2026-2027.
Another significant item scheduled for discussion is the approval of Mr. Hemant Amrish Parikh's appointment as a Non-Executive Non-Independent Director of the company.
The meeting will also address the transfer of certain unverified shares to the Unclaimed Suspense Account. The authorization detailed in the agenda permits the Registrar and Share Transfer Agent (RTA) to process and release these shares from the Unclaimed Suspense Account once the Company receives and verifies the prescribed KYC and supporting documents, subject to confirmation by the company and applicable laws.
The board is expected to cover all matters with the permission of the chair.
Stock Price Movement
Vivanza Biosciences Ltd. shares are ticking up as of 10:14, with the stock currently trading at ₹1.71, gaining +0.59%. The stock's movement has been contained within a tight intraday range, moving between ₹1.70 and ₹1.71.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.